Revenue
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
CVS HEALTH Corp (CVS)
Price$88.40Cached quote
Net income
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B | $256.78B | $193.92B | $184.76B | $177.53B | $153.29B | $139.37B | $126.76B | $123.12B | $107.08B | $95.78B | $98.22B | $87.47B | $76.33B |
| Gross profit | $180.90B | $166.52B | $140.68B | $125.58B | $116.31B | $104.72B | $98.06B | $37.47B | $28.55B | $28.86B | $26.53B | $25.37B | $23.78B | $22.49B | $20.56B | $20.22B | $20.36B | $18.29B | $16.11B |
| Gross margin | 44.99% | 44.67% | 39.32% | 38.94% | 39.82% | 38.97% | 38.19% | 19.32% | 15.45% | 16.26% | 17.31% | 18.20% | 18.76% | 18.27% | 19.20% | 21.11% | 20.73% | 20.91% | 21.10% |
| Operating expenses | $397.41B | $364.29B | $344.03B | $314.51B | $278.80B | $254.79B | $244.79B | $190.56B | $175.25B | $167.16B | $17.05B | $16.57B | $15.75B | $15.28B | $14.23B | $14.08B | $13.93B | $12.24B | $11.31B |
| Operating income | $4.66B | $8.52B | $13.74B | $7.95B | $13.31B | $13.91B | $11.99B | $4.02B | $9.54B | $10.39B | $9.47B | $8.80B | $8.04B | $7.21B | $6.33B | $6.14B | $6.42B | $6.05B | $4.79B |
| Operating margin | 1.16% | 2.28% | 3.84% | 2.47% | 4.56% | 5.18% | 4.67% | 2.07% | 5.16% | 5.85% | 6.18% | 6.31% | 6.34% | 5.86% | 5.91% | 6.41% | 6.54% | 6.91% | 6.28% |
| EBITDA | $9.27B | $13.11B | $18.11B | $12.18B | $17.80B | $18.35B | $16.36B | $6.74B | $12.02B | $12.86B | $11.57B | $10.73B | $9.91B | $8.96B | $7.90B | $7.61B | $7.81B | $7.32B | $5.89B |
| EBITDA margin | 2.30% | 3.52% | 5.06% | 3.78% | 6.09% | 6.83% | 6.37% | 3.48% | 6.50% | 7.24% | 7.55% | 7.70% | 7.82% | 7.28% | 7.38% | 7.94% | 7.96% | 8.37% | 7.72% |
| Net income | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B | $6.63B | −$594.0M | $6.62B | $5.32B | $5.24B | $4.64B | $4.59B | $3.86B | $3.46B | $3.43B | $3.70B | $3.20B | $2.64B |
| Net profit margin | 0.44% | 1.24% | 2.33% | 1.34% | 2.74% | 2.67% | 2.58% | −0.31% | 3.58% | 3.00% | 3.42% | 3.33% | 3.62% | 3.14% | 3.23% | 3.58% | 3.76% | 3.66% | 3.45% |
| Basic EPSper basic share | $1.40 | $3.67 | $6.49 | $3.29 | $6.07 | $5.48 | $5.10 | -$0.57 | $6.47 | $4.93 | $4.66 | $3.98 | $3.77 | $3.04 | $2.59 | $2.51 | $2.58 | $2.23 | $1.97 |
| Diluted EPSper diluted share | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 | $5.46 | $5.08 | -$0.57 | $6.44 | $4.90 | $4.63 | $3.96 | $3.74 | $3.02 | $2.57 | $2.49 | $2.55 | $2.18 | $1.92 |
Owners
Reported shareholders
9.64%of listed shares
BlackRock, Inc.123.22M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 9.64%123.22M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 6.52%83.32M shares |
Capital World Investors | 5.86%74.95M shares |
STATE STREET CORP | 4.72%60.28M shares |
Dodge & Cox | 3.91%50.01M shares |
WELLINGTON MANAGEMENT GROUP LLP | 2.64%33.8M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.34%29.9M shares |
FMR LLC | 2.26%28.92M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 2.08%26.64M shares |
Capital Research Global Investors | 1.90%24.33M shares |
PRICE T ROWE ASSOCIATES INC /MD/ | 1.89%24.2M shares |
BANK OF AMERICA CORP /DE/ | 1.81%23.19M shares |
JPMORGAN CHASE & CO | 1.73%22.11M shares |
Invesco Ltd. | 1.61%20.6M shares |
MORGAN STANLEY | 1.46%18.61M shares |
NORGES BANK | 1.41%18.04M shares |
Capital International Investors | 1.20%15.39M shares |
GOLDMAN SACHS GROUP INC | 1.05%13.41M shares |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.04%13.26M shares |
Davis Selected Advisers | 0.93%11.87M shares |
Percentages use 1.28B shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 21, 2026Form 4 | ROBBINS LARRYDirector | SellCommon Stock · indirect | 370.5K | $93.45 | $34.62M | 4.82M |
| May 21, 2026Form 4 | ROBBINS LARRYDirector | SellCash-Settled Swaps · derivative · indirect | 378.0K | $93.31 | $35.27M | 0 |
| May 20, 2026Form 4 | ROBBINS LARRYDirector | SellCommon Stock · indirect | 800 | $96.28 | $77.0K | 5.20M |
| May 20, 2026Form 4 | ROBBINS LARRYDirector | SellCommon Stock · indirect | 66.9K | $95.67 | $6.40M | 5.20M |
| May 20, 2026Form 4 | ROBBINS LARRYDirector | SellCommon Stock · indirect | 152.7K | $94.81 | $14.48M | 5.26M |